To bring together the very best investment, scientific and philanthropic minds globally to maximise medical research funding in Australia.
Conceived in 2016 by co-founders Gary Weiss, Matthew Grounds and Guy Fowler who sought to present a different type of investment conference in Australia.
Taking inspiration from partner Sohn Conference Foundation and with the creative direction of Delorean, the conference quickly drew support from major partner CBA, as well as prominent investor organisations, individuals, and media partners.
Top investors who rarely speak in public, agreed to present an 8 minute TEDx-style pitch on their ‘best investment idea’, committing their time and expertise in support of medical research. The conference is proud to have many speakers and supporters continue their commitment over several years.
Our strategic partners
Commonwealth Bank of Australia
The Commonwealth Bank of Australia (CBA) has been a foundational partner of the conference since its inception. Through this major partnership CommSec developed a bespoke event app, giving attendees a unique platform to engage with the ideas presented on the day.
Paul Ramsay Foundation
In 2018 the Paul Ramsay Foundation joined as a major partner, committing to dollar match all monies raised by the conference. This generous contribution doubles the impact we are able to make on the health of our communities.
Learn more about the philanthropic objectives and innovations of the Paul Ramsay Foundation here.
The Sohn Conference Foundation
Partnership with the Sohn Investment Conference is intrinsic to Hearts & Minds.
Held annually in New York since 1995, it is the original premier investment event, which is now hosted globally in ten cities. We are proud to be the exclusive Australian affiliate of this hugely impactful organisation.
Why Support Medical Research?
Strong investment in medical research is the only clear and direct avenue to curing many diseases. Sohn Hearts & Minds recognises this and is the largest single fundraising event for medical research in Australia. Key reasons to support medical research:
||Development of new medicine
Every person in Australia has benefited from the results of medical research, from the development of new drugs, vaccines, or procedures to prevent or treat diseases and safety testing of products.
||Excellent return on investment
Medical research provides an excellent return on investment. Investment in medical research between 1993 and 2005 is estimated to have returned a net benefit of $29.5 billion to Australia. Every dollar invested in medical research returns on average $2.17 in health benefits.2
||Australia is a world-leader
Australia produces quality medical research. Australian scientists are responsible for some of the world’s most important and life-changing medical discoveries. Australia is ranked 8th in the world for producing the top scientific publications per capita (ahead of the U.S. and the U.K) 1
||Support a new generation of researchers
To tackle the clinical problems of today, and those yet to come, we must find a way to support medical research and encourage our best and brightest minds follow a career in science.
||1. Organisation for Economic Co-operation and Development (OECD). (2015). OECD Science, Technology and Industry Scoreboard 2015. Section 2.6.1 The quantity and quality of scientific production. Geneva OECD. Available from http://dx.doi.org/10.1787/888933273656 (per capita data derived from OECD dataset) 2. Access Economics. Exceptional returns: The value of investing in health R&D in Australia II. Canberra: Australian Society for Medical Research; 2008. Available from: www.asmr.org.au/ExceptII08.pdf
Medical Research Institute Partners